What is MedTech Color?
MedTech Color is a non-profit organization focused on ensuring people of color enter, remain, and flourish in the medtech industry. There is immense untapped potential from people of color, and we’re committed to providing and promoting opportunities for them to make a meaningful contribution to the industry.
JOHN WHYTE: You’re watching “Coronavirus in Context.” I’m Dr. John Whyte, chief medical officer at WebMD. Today I’m joined by Dr. Stephen Hahn. He’s the commissioner of the US Food and Drug Administration. Dr. Hahn, thanks for joining me.
STEPHEN M HAHN: John, thank you. Really appreciate the opportunity, and it’s great to be part of this webcast.
Image: Stephen M. Hahn M.D.
To meet the Trump Administration’s Operation Warp Speed goals, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) today announced an agreement with AstraZeneca for late-stage development and large-scale manufacturing of the company’s COVID-19 investigational product AZD7442, a cocktail of two monoclonal antibodies, that may help treat or prevent infection with SARS-CoV-2, the coronavirus that causes COVID-19.
Not every research project succeeds. And not every company survives. However, the ones that align with the culture of winning and sign up and adopt the community charter are opting in for a much higher chance of disrupting their industry and changing the rules of the game.
So, you are probably thinking it’s not important, right?
But it is… At the Virginia Tech Corporate Research Center, we have the unique ability to witness effective project teams daily. With over 200 companies creating breakthroughs from nanomaterials to self-driving vehicles, we have a ready-made ‘team laboratory’ to understand what works and how to scale.
Image: Brett Malone, Ph.D., President & CEO Virginia Tech Corporate Research Center
Montgomery County Executive Marc Elrich joins BioTalk to discuss his Career Path, the BioHealth Industry and plans to support the Industry in MoCo.
Listen now on Apple https://apple.co/37dYS5Z, Google https://bit.ly/2IC4eOp, Spotify https://spoti.fi/2IDpN11, TuneIn https://bit.ly/31cjHuZ, and YouTube (Audio) https://bit.ly/31bsiho.
BARDA Director of the DRIVe Catalyst Office, Justin Yang, Joins BioTalk to share how BARDA collaborates with the BioHealth Industry, partners with Incubators, and helps fund innovation.
Listen now via Apple https://apple.co/3dqDyLH, Google https://bit.ly/3jZyeRU, Spotify https://spoti.fi/34YL9xg, and TuneIn https://bit.ly/3k1uM9x.
Across the world in 2019, UNICEF reports that over 2.4 million infants died in their first month of life, the vast majority in the developing world.
The situation in sub-Saharan Africa is particularly dire: an infant born in that region is 10 times more likely to die during its first month of life than a child born in a high-income country. Most of these deaths are preventable.
It was statistics like these that inspired biomedical engineers Sona Shah and Teresa Cauvel to found Neopenda in 2015.
Neopenda, a Cisco social entrepreneurship prize winner, is a social enterprise that develops innovative technologies for health systems in underserved populations.
Children’s National Hospital has received 2020 Digital Health Most Wired recognition by The College of Healthcare Information Management Executives (CHIME) as a certified level eight. The CHIME Digital Health Most Wired program conducts an annual survey to assess how effectively health care organizations apply core and advanced technologies into their clinical and business programs to improve health and care in their communities.
“Children’s National is honored to receive the Most Wired recognition for our inpatient and ambulatory venues,” said Matt MacVey, vice president and chief information officer at Children’s National. “We have made substantial investments in technology in support of our mission to provide a high-quality experience and optimal health outcomes for children regionally, nationally and internationally.”
ROCKVILLE, Md.–(BUSINESS WIRE)–Oct. 5, 2020– GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle cell disease in patients 18 years old and younger. This designation recognizes the significant needs in pediatric patients.
“The FDA’s designation recognizes the morbidity and mortality burdens of sickle cell disease as well as its significant impact during childhood with life-long implications. With this designation, the agency acknowledges the urgent need for improved treatment of children living with sickle cell disease,” stated Helen Thackray, Chief Medical Officer of GlycoMimetics.
In the early days of managing the Johns Hopkins COVID-19 dashboard, experts at the university and those at Esri, the company providing the mapping software for the real-time pandemic tracker, had a friendly rivalry.
“They would tell us, ‘Oh, your COVID map is big, but not as big as our Pokémon Go map,’ which was their most in demand,” says Reina Murray, an application administrator at JHU’s Sheridan Libraries.
By March, the volume of web traffic to the Hopkins map effectively shut down that conversation—the Hopkins dashboard now holds the record as Esri’s highest-used service of all time, drawing hundreds of millions of feature requests every day. At a peak in March, the dashboard saw 4.56 billion feature requests.
Image: https://hub.jhu.edu/
